Author Correction: Secukinumab Demonstrates Significantly Lower Immunogenicity Potential Compared to Ixekizumab
Crossref DOI link: https://doi.org/10.1007/s13555-018-0234-5
Published Online: 2018-03-17
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Spindeldreher, Sebastian
Maillère, Bernard
Correia, Evelyne
Tenon, Maxime
Karle, Anette
Jarvis, Philip
Kolbinger, Frank
Text and Data Mining valid from 2018-03-17
Article History
First Online: 17 March 2018